Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
VolitionRX Ltd (VNRX)
USD1.17
-0.11 (-8.24%)
US AMEX Healthcare Medical - Specialties
Address
1489 West Warm Springs Road 89014
Henderson, NV, US
Henderson, NV, US
CEO
Cameron Reynolds
Website
volition.com
IPO
2012-03-02
CIK 93314 ISIN US9286612067
Description
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.17
-0.11 (-8.24%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
296.8K
Beta
1.04
Float Shares
5.35M
Free Float %
100.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.72% | -1.67% | -26.71% | -47.90% | -66.71% | -53.82% | -74.79% | -93.14% | -96.08% | -96.55% | -96.07% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (8 ratings, all time)
Buy
Price Targets & DCF
Current price
1.17
Ratings Trend (MoM)
60% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | -1 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-62.70
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Specialties: +8.3%+40.0% ★ Q1'26: +299.8% (vs Q1'25)
-
EPS growth Medical - Specialties: +10.1%+29.0% ★ Q1'26: +13.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Specialties: +51.3%-1,346.7% Q1'26: -536.9% (vs Q1'25)
-
EBIT margin Medical - Specialties: +12.6%-1,216.5% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Specialties: +6.6%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Specialties: 0.0%+23.5% Q1'26: +42.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Specialties: -0.39×-0.58×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 88.0K (-100.0%)
|
17.1K
est: 21.0K (-18.6%)
|
13.4K
est: 8.1K (+66.3%)
|
90.0K
est: 101.8K (-11.5%)
|
306.4K
est: 373.2K (-17.9%)
|
775.3K
est: 976.5K (-20.6%)
|
1.23M
est: 1.45M (-15.2%)
|
1.73M
est: 1.75M (-1.5%)
|
6.77M
6.44M – 7.10M
+285.8% YoY
|
49.97M
3.87M – 137.04M
+638.3% YoY
|
81.52M
11.15M – 232.39M
+63.1% YoY
|
172.31M
23.57M – 491.22M
+111.4% YoY
|
236.11M
32.29M – 673.10M
+37.0% YoY
|
| EBITDA |
-17.26M
est: -88.0K (-19,511.1%)
|
-15.07M
est: -16.41M (+8.2%)
|
-19.23M
est: -8.1K (-237,871.8%)
|
-25.69M
est: -101.8K (-25,139.8%)
|
-29.24M
est: -373.2K (-7,734.7%)
|
-34.04M
est: -976.5K (-3,386.1%)
|
-25.58M
est: -1.45M (-1,658.0%)
|
-19.80M
est: -1.75M (-1,028.6%)
|
-6.77M
-7.10M – -6.44M
-285.8% YoY
|
-49.97M
-137.04M – -3.87M
-638.3% YoY
|
-81.52M
-232.39M – -11.15M
-63.1% YoY
|
-172.31M
-491.22M – -23.57M
-111.4% YoY
|
-236.11M
-673.10M – -32.29M
-37.0% YoY
|
| EBIT |
-17.90M
est: -88.0K (-20,238.3%)
|
-15.97M
est: -17.13M (+6.7%)
|
-20.27M
est: -8.1K (-250,760.1%)
|
-26.83M
est: -101.8K (-26,264.9%)
|
-30.43M
est: -373.2K (-8,053.6%)
|
-35.46M
est: -976.5K (-3,530.8%)
|
-26.92M
est: -1.45M (-1,750.0%)
|
-21.01M
est: -1.75M (-1,097.9%)
|
-6.77M
-7.10M – -6.44M
-285.8% YoY
|
-49.97M
-137.04M – -3.87M
-638.3% YoY
|
-81.52M
-232.39M – -11.15M
-63.1% YoY
|
-172.31M
-491.22M – -23.57M
-111.4% YoY
|
-236.11M
-673.10M – -32.29M
-37.0% YoY
|
| Net Income |
-18.01M
est: -49.15M (+63.4%)
|
-16.10M
est: -17.19M (+6.3%)
|
-20.35M
est: -38.07M (+46.5%)
|
-26.81M
est: -43.09M (+37.8%)
|
-30.27M
est: -33.24M (+8.9%)
|
-35.32M
est: -3.53M (-900.9%)
|
-26.97M
est: -23.32M (-15.6%)
|
-23.36M
est: -9.26M (-152.2%)
|
-10.43M
-11.30M – -9.56M
-12.6% YoY
|
12.46M
-3.12M – 28.04M
+219.5% YoY
|
58.77M
-13.89M – 86.53M
+371.5% YoY
|
64.10M
-7.83M – 218.32M
+9.1% YoY
|
87.07M
-10.64M – 296.56M
+35.8% YoY
|
| SGA |
6.95M
est: 12.99M (-46.5%)
|
5.49M
est: 3.10M (+77.0%)
|
6.54M
est: 1.19M (+448.4%)
|
14.83M
est: 15.02M (-1.3%)
|
16.40M
est: 55.07M (-70.2%)
|
16.92M
est: 50.55M (-66.5%)
|
13.64M
est: 75.32M (-81.9%)
|
13.38M
est: 90.81M (-85.3%)
|
350.36M
333.20M – 367.52M
+285.8% YoY
|
2.59B
200.26M – 7.09B
+638.3% YoY
|
4.22B
577.14M – 12.03B
+63.1% YoY
|
8.92B
1.22B – 25.43B
+111.4% YoY
|
12.22B
1.67B – 34.85B
+37.0% YoY
|
| EPS |
-11.40
est: -0.57 (-1,907.0%)
|
-8.20
est: -0.45 (-1,742.7%)
|
-9.00
est: -0.44 (-1,945.5%)
|
-10.20
est: -0.50 (-1,948.2%)
|
-11.00
est: -0.57 (-1,829.8%)
|
-10.00
est: -0.40 (-2,385.5%)
|
-6.20
est: -6.10 (-1.6%)
|
-4.40
est: -1.73 (-153.7%)
|
-1.95
-2.12 – -1.79
-12.6% YoY
|
2.33
-0.58 – 5.25
+219.5% YoY
|
4.73
-2.60 – 16.20
+102.9% YoY
|
12.00
-1.47 – 40.87
+153.5% YoY
|
16.30
-1.99 – 55.52
+35.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | D. Boral Capital | Buy | Hold | Downgrade |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-15.37M
OE per share TTM
-3.00
Owner's Yield
-121.90%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
860.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
15
Total invested
484.8K
Insider transactions (90d)
0
Beneficial owners (>5%)
9
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COTTERFORD COMPANY LIMITED | 11.09M | 27.50% | — | 11.09M | — | 11.09M | FI | ISLE OF MAN | 2019-01-03 | ↗ |
| 2 | Armistice Capital, LLC | 9.22M | 9.99% | — | 9.22M | — | — | IA, OO | Delaware | 2024-11-14 | ↗ |
| 3 | Steven Boyd | 9.22M | 9.99% | — | 9.22M | — | — | HC, IN | Delaware | 2024-11-14 | ↗ |
| 4 | Lagoda Investment Management, L.P. 46-4740139 | 2.93M | 11.40% | 2.93M | — | 2.93M | — | IA | Delaware | 2017-01-24 | ↗ |
| 5 | Cameron Reynolds | 2.67M | 5.10% | 1.63M | 1.04M | 1.63M | 11.00 | IN | — | 2021-03-01 | ↗ |
| 6 | Guy Archibald Innes | 1.93M | 3.70% | 1.52M | 405.7K | 1.52M | 11.00 | IN | — | 2021-03-01 | ↗ |
| 7 | J.P.Morgan Chase & Co. | 1.68M | 6.20% | — | 11.88M | — | 11.88M | HC | ISLE OF MAN | 2019-01-03 | ↗ |
| 8 | James E. Besser | 1.08M | 7.20% | 200.0K | 881.0K | 200.0K | 881.0K | IN | Delaware | 2015-01-22 | ↗ |
| 9 | Manchester Management Company, LLC | 881.0K | 5.90% | — | 881.0K | — | 881.0K | OO | Delaware | 2015-01-22 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
15
-13 vs prev Q
New positions
9
Closed positions
22
Increased
12
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | LAGODA INVESTMENT MANAGEMENT, L.P. | 11.46M -1.0M (-8.2%) | 2.93M -5.5M (-65.4%) | 10.59% -1.571 pp | 1.70% -3.099 pp | USD1.49 -82.6% | 40 qtrs — |
| 2 | VANGUARD GROUP INC | 1.53M +— (+0.0%) | 391.7K -647.2K (-62.3%) | 1.41% -0.077 pp | 0.00% +0.000 pp | USD1.69 -84.6% | 38 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 964.0K +85.8K (+9.8%) | 246.4K -349.8K (-58.7%) | 0.89% +0.035 pp | 0.00% +0.000 pp | USD1.78 -85.4% | 40 qtrs — |
| 4 | BLACKROCK, INC. | 445.2K +— (+0.0%) | 113.8K -188.4K (-62.3%) | 0.41% -0.022 pp | 0.00% +0.000 pp | USD0.60 -56.7% | 6 qtrs — |
| 5 | STATE STREET CORP | 311.5K +42.9K (+16.0%) | 79.6K -102.7K (-56.3%) | 0.29% +0.026 pp | 0.00% +0.000 pp | USD1.80 -85.6% | 25 qtrs — |
| 6 | NORTHERN TRUST CORP | 259.6K +66.7K (+34.6%) | 66.4K -64.6K (-49.3%) | 0.24% +0.052 pp | 0.00% +0.000 pp | USD1.25 -79.2% | 38 qtrs — |
| 7 | SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC | 249.3K +17.2K (+7.4%) | 63.7K -93.7K (-59.5%) | 0.23% +0.004 pp | 0.04% -0.059 pp | USD0.69 -62.3% | 9 qtrs — |
| 8 | CITADEL ADVISORS LLC | 167.7K -161.8K (-49.1%) | 42.9K -180.8K (-80.8%) | 0.16% -0.166 pp | 0.00% +0.000 pp | USD0.73 -64.4% | 7 qtrs — |
| 9 | SQUAREPOINT OPS LLC | 134.7K +134.7K (+100.0%) | 34.4K +34.4K (+100.0%) | 0.12% +0.124 pp | 0.00% +0.000 pp | USD0.26 +0.0% | 4 qtrs — |
| 10 | JANE STREET GROUP, LLC | 111.4K +111.4K (+100.0%) | 28.5K +28.5K (+100.0%) | 0.10% +0.103 pp | 0.00% +0.000 pp | USD0.26 +0.0% | 1 qtrs NEW |
| 11 | VIRTU FINANCIAL LLC | 108.6K +67.8K (+166.6%) | 28.0K +— (+0.0%) | 0.10% +0.061 pp | 0.00% -0.001 pp | USD0.41 -36.6% | 2 qtrs — |
| 12 | WARBERG ASSET MANAGEMENT LLC | 90.8K +90.8K (+100.0%) | 23.2K +23.2K (+100.0%) | 0.08% +0.084 pp | 0.00% +0.003 pp | USD0.26 +0.0% | 1 qtrs NEW |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56.8K +56.8K (+100.0%) | 14.5K +14.5K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.000 pp | USD0.26 +0.0% | 8 qtrs — |
| 14 | BANK OF NEW YORK MELLON CORP | 55.6K +25.0K (+81.7%) | 14.2K -6.6K (-31.6%) | 0.05% +0.022 pp | 0.00% +0.000 pp | USD0.43 -39.5% | 4 qtrs — |
| 15 | GROUP ONE TRADING, L.P. | 50.0K +50.0K (+100.0%) | 12.8K +12.8K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.000 pp | USD0.26 +0.0% | 1 qtrs NEW |
| 16 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 40.0K -28.6K (-41.7%) | 10.2K -36.3K (-78.0%) | 0.04% -0.030 pp | 0.00% +0.000 pp | USD0.76 -65.8% | 3 qtrs — |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 25.3K -52.7K (-67.6%) | 6.5K -46.5K (-87.8%) | 0.02% -0.053 pp | 0.00% 0.000 pp | USD0.70 -62.9% | 3 qtrs — |
| 18 | CETERA INVESTMENT ADVISERS | 20.6K +500.0 (+2.5%) | 5.3K -8.4K (-61.4%) | 0.02% -0.001 pp | 0.00% +0.000 pp | USD0.67 -61.2% | 2 qtrs — |
| 19 | TOWER RESEARCH CAPITAL LLC (TRC) | 16.0K +11.5K (+262.0%) | 4.1K +1.1K (+36.3%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD0.37 -29.7% | 36 qtrs — |
| 20 | TWO SIGMA SECURITIES, LLC | 14.6K +14.6K (+100.0%) | 3.7K +3.7K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.001 pp | USD0.26 +0.0% | 1 qtrs NEW |
| 21 | CHICAGO PARTNERS INVESTMENT GROUP LLC | 12.0K -4.2K (-25.8%) | 3.4K -3.5K (-50.7%) | 0.01% -0.005 pp | 0.00% 0.000 pp | USD0.57 -54.4% | 4 qtrs — |
| 22 | CREATIVE PLANNING | 12.8K +2.8K (+27.6%) | 3.3K -3.5K (-51.9%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD0.53 -50.9% | 5 qtrs — |
| 23 | BANK OF AMERICA CORP /DE/ | 960.00 +— (+0.0%) | 245.00 -405.0 (-62.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.66 -60.6% | 7 qtrs — |
| 24 | MORGAN STANLEY | 665.00 -135.0 (-16.9%) | 170.00 -373.0 (-68.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.48 -82.4% | 44 qtrs — |
| 25 | ADVISOR GROUP HOLDINGS, INC. | 430.00 +— (+0.0%) | 110.00 -182.0 (-62.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.68 -61.8% | 2 qtrs — |
| 26 | UBS GROUP AG | 310.00 -14.5K (-97.9%) | 79.00 -10.0K (-99.2%) | 0.00% -0.014 pp | 0.00% +0.000 pp | USD0.68 -61.8% | 44 qtrs — |
| 27 | BNP PARIBAS ARBITRAGE, SNC | 265.00 +— (+0.0%) | 68.00 -112.0 (-62.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.26 -92.0% | 23 qtrs — |
| 28 | SBI SECURITIES CO., LTD. | 117.00 +— (+0.0%) | 30.00 -49.0 (-62.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.74 -64.9% | 3 qtrs — |
| 29 | FOUNDERS CAPITAL MANAGEMENT | — -2.0K (-100.0%) | — -1.4K (-100.0%) | 0.00% -0.002 pp | 0.00% -0.001 pp | USD— | 19 qtrs SOLD |
| 30 | FMR LLC | — -700.0 (-100.0%) | — -475.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 31 | CITIGROUP INC | — -348.0 (-100.0%) | — -236.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 32 | ARMISTICE CAPITAL, LLC | — -9.4M (-100.0%) | — -6.4M (-100.0%) | 0.00% -9.138 pp | 0.00% -0.095 pp | USD— | 6 qtrs SOLD |
| 33 | AMERITAS ADVISORY SERVICES, LLC | — -4.0K (-100.0%) | — -2.7K (-100.0%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 34 | ALLWORTH FINANCIAL LP | — -200.0 (-100.0%) | — -136.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 35 | ROYAL BANK OF CANADA | — -6.6K (-100.0%) | — -4.0K (-100.0%) | 0.00% -0.006 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 36 | XTX TOPCO LTD | — -35.7K (-100.0%) | — -24.2K (-100.0%) | 0.00% -0.035 pp | 0.00% -0.001 pp | USD— | 5 qtrs SOLD |
| 37 | MILLENNIUM MANAGEMENT LLC | — -29.4K (-100.0%) | — -19.9K (-100.0%) | 0.00% -0.029 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 38 | HRT FINANCIAL LP | — -16.6K (-100.0%) | — -11.0K (-100.0%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 132.3K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.70
Bullish
Ratio by volume
3.00
Bullish
Buys
27
Sells
10
Shares acquired
2.70M
Shares disposed
43.8K
Cash buys
—
Cash sales
—
Net activity
+2,658,764
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 3,948 | 0.19 | 750.12 | 273,993 | D | ↗ |
| 2026-03-17 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 7,003 | 0.19 | 1.3K | 407,267 | D | ↗ |
| 2026-03-17 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 5,310 | 0.19 | 1.0K | 572,179 | D | ↗ |
| 2026-03-17 | Forterre Gael | Officer | F-InKind | D | Common Stock | 5,251 | 0.19 | 997.69 | 331,338 | D | ↗ |
| 2026-03-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 3,321 | 0.21 | 707.37 | 277,941 | D | ↗ |
| 2026-03-01 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 5,867 | 0.21 | 1.2K | 414,270 | D | ↗ |
| 2026-03-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 2,283 | 0.21 | 486.28 | 336,589 | D | ↗ |
| 2026-02-26 | Rubin Ethel | Director | A-Award | A | Common Stock | 178,000 | 0.00 | — | 252,948 | D | ↗ |
| 2026-02-26 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 119,000 | 0.00 | — | 281,262 | D | ↗ |
| 2026-02-26 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 486,000 | 0.00 | — | 3,115,547 | D | ↗ |
| 2026-02-26 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 187,000 | 0.00 | — | 420,137 | D | ↗ |
| 2026-02-26 | Nguyen Kim | Director | A-Award | A | Common Stock | 178,000 | 0.00 | — | 305,816 | D | ↗ |
| 2026-02-26 | Micallef Jacob Vincent | Officer | A-Award | A | Common Stock | 149,000 | 0.00 | — | 577,489 | D | ↗ |
| 2026-02-26 | Kway Jasmine | Officer | A-Award | A | Common Stock | 173,000 | 0.00 | — | 418,614 | D | ↗ |
| 2026-02-26 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 178,000 | 0.00 | — | 1,252,967 | D | ↗ |
| 2026-02-26 | Hughes Terig | Officer | A-Award | A | Common Stock | 202,000 | 0.00 | — | 684,970 | D | ↗ |
| 2026-02-26 | Forterre Gael | Officer | A-Award | A | Common Stock | 149,000 | 0.00 | — | 338,872 | D | ↗ |
| 2026-02-26 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 142,000 | 0.00 | — | 324,072 | D | ↗ |
| 2026-02-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 3,196 | 0.29 | 910.86 | 162,262 | D | ↗ |
| 2026-02-01 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 5,647 | 0.29 | 1.6K | 233,137 | D | ↗ |
| 2026-02-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 2,010 | 0.29 | 572.85 | 189,872 | D | ↗ |
| 2026-01-22 | STILL TIMOTHY I | Director | A-Award | A | Common Stock | 90,000 | 0.00 | — | 1,625,458 | D | ↗ |
| 2026-01-22 | Rubin Ethel | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 74,948 | D | ↗ |
| 2026-01-22 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 28,200 | 0.00 | — | 165,458 | D | ↗ |
| 2026-01-22 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 74,700 | 0.00 | — | 2,629,547 | D | ↗ |
| 2026-01-22 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 44,700 | 0.00 | — | 238,784 | D | ↗ |
| 2026-01-22 | Nguyen Kim | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 127,816 | D | ↗ |
| 2026-01-22 | Micallef Jacob Vincent | Officer | A-Award | A | Common Stock | 35,400 | 0.00 | — | 428,489 | D | ↗ |
| 2026-01-22 | Kway Jasmine | Officer | A-Award | A | Common Stock | 42,000 | 0.00 | — | 245,614 | D | ↗ |
| 2026-01-22 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 1,074,967 | D | ↗ |
| 2026-01-22 | Hughes Terig | Officer | A-Award | A | Common Stock | 49,200 | 0.00 | — | 482,970 | D | ↗ |
| 2026-01-22 | Henshall Mickie | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 44,206 | D | ↗ |
| 2026-01-22 | Forterre Gael | Officer | A-Award | A | Common Stock | 38,100 | 0.00 | — | 191,882 | D | ↗ |
| 2026-01-22 | Colman Alan | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 257,364 | D | ↗ |
| 2026-01-22 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 53,400 | 0.00 | — | 375,203 | D | ↗ |
| 2026-01-22 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 33,900 | 0.00 | — | 182,072 | D | ↗ |
| 2026-01-22 | Barnes Phillip | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 67,368 | D | ↗ |
| 2025-11-17 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.35 | 7.0K | 2,554,847 | D | ↗ |
| 2025-11-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 3,197 | 0.43 | 1.4K | 137,258 | D | ↗ |
| 2025-11-01 | Retter Andrew | Officer | F-InKind | D | Common Stock | 4,588 | 0.43 | 2.0K | 146,568 | D | ↗ |
| 2025-11-01 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 5,647 | 0.43 | 2.5K | 194,084 | D | ↗ |
| 2025-11-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 1,753 | 0.43 | 760.80 | 153,782 | D | ↗ |
| 2025-11-01 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 4,648 | 0.43 | 2.0K | 321,803 | D | ↗ |
| 2025-10-14 | STILL TIMOTHY I | Director | P-Purchase | A | Warrant (Right to Buy) | 48,076 | 0.60 | 28.8K | 48,076 | D | ↗ |
| 2025-10-14 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 110,000 | 0.51 | 56.1K | 2,534,847 | D | ↗ |
| 2025-10-14 | Innes Guy Archibald | Director | P-Purchase | A | Warrant (Right to Buy) | 96,153 | 0.60 | 57.7K | 96,153 | D | ↗ |
| 2025-10-04 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 4,620 | 0.65 | 3.0K | 140,455 | D | ↗ |
| 2025-10-04 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 8,146 | 0.65 | 5.3K | 199,731 | D | ↗ |
| 2025-10-04 | Michel Gaetan | Officer | F-InKind | D | Common Stock | 12,333 | 0.65 | 8.0K | 256,746 | D | ↗ |
| 2025-10-04 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 5,850 | 0.65 | 3.8K | 393,089 | D | ↗ |
| 2025-10-04 | Forterre Gael | Officer | F-InKind | D | Common Stock | 5,389 | 0.65 | 3.5K | 155,535 | D | ↗ |
| 2025-10-04 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 5,834 | 0.65 | 3.8K | 326,451 | D | ↗ |
| 2025-10-04 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 6,110 | 0.65 | 4.0K | 148,172 | D | ↗ |
| 2025-09-28 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 4,158 | 0.61 | 2.5K | 145,075 | D | ↗ |
| 2025-09-28 | Michel Gaetan | Officer | F-InKind | D | Common Stock | 11,362 | 0.61 | 6.9K | 369,079 | D | ↗ |
| 2025-09-28 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 5,568 | 0.61 | 3.4K | 398,939 | D | ↗ |
| 2025-09-28 | Forterre Gael | Officer | F-InKind | D | Common Stock | 5,503 | 0.61 | 3.3K | 160,924 | D | ↗ |
| 2025-09-28 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 5,230 | 0.61 | 3.2K | 332,285 | D | ↗ |
| 2025-09-28 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 5,604 | 0.61 | 3.4K | 154,282 | D | ↗ |
| 2025-09-12 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 15,000 | 0.66 | 9.9K | 2,624,847 | D | ↗ |
| 2025-08-15 | Rubin Ethel | Director | A-Award | A | Common Stock | 17,424 | 0.00 | — | 62,948 | D | ↗ |
| 2025-08-15 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 15,223 | 0.00 | — | 149,233 | D | ↗ |
| 2025-08-15 | Retter Andrew | Officer | A-Award | A | Common Stock | 19,524 | 0.00 | — | 151,156 | D | ↗ |
| 2025-08-15 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 24,031 | 0.00 | — | 207,877 | D | ↗ |
| 2025-08-15 | Nguyen Kim | Director | A-Award | A | Common Stock | 17,424 | 0.00 | — | 115,816 | D | ↗ |
| 2025-08-15 | Kway Jasmine | Officer | A-Award | A | Common Stock | 12,507 | 0.00 | — | 203,614 | D | ↗ |
| 2025-08-15 | Hughes Terig | Officer | A-Award | A | Common Stock | 26,143 | 0.00 | — | 533,770 | D | ↗ |
| 2025-08-15 | Forterre Gael | Officer | A-Award | A | Common Stock | 9,727 | 0.00 | — | 166,427 | D | ↗ |
| 2025-08-15 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 33,991 | 0.00 | — | 337,515 | D | ↗ |
| 2025-08-15 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 27,400 | 0.00 | — | 159,886 | D | ↗ |
| 2025-08-05 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 78,125 | 0.64 | 50.0K | 2,609,847 | D | ↗ |
| 2025-08-05 | Innes Guy Archibald | Director | P-Purchase | A | Common Stock | 78,125 | 0.64 | 50.0K | 966,814 | D | ↗ |
| 2025-08-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 4,279 | 0.64 | 2.7K | 134,010 | D | ↗ |
| 2025-08-01 | Retter Andrew | Officer | F-InKind | D | Common Stock | 6,142 | 0.64 | 3.9K | 131,632 | D | ↗ |
| 2025-08-01 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 4,451 | 0.64 | 2.8K | 183,846 | D | ↗ |
| 2025-08-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 2,766 | 0.64 | 1.8K | 156,700 | D | ↗ |
| 2025-08-01 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 6,393 | 0.64 | 4.1K | 303,524 | D | ↗ |
| 2025-08-01 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 8,620 | 0.64 | 5.5K | 132,486 | D | ↗ |
| 2025-07-24 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 2,531,722 | D | ↗ |
| 2025-07-24 | Hughes Terig | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 507,627 | D | ↗ |
| 2025-07-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 3,066 | 0.77 | 2.4K | 138,289 | D | ↗ |
| 2025-07-01 | Retter Andrew | Officer | F-InKind | D | Common Stock | 4,401 | 0.77 | 3.4K | 137,774 | D | ↗ |
| 2025-07-01 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 5,417 | 0.77 | 4.2K | 188,297 | D | ↗ |
| 2025-07-01 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 4,462 | 0.77 | 3.4K | 309,917 | D | ↗ |
| 2025-07-01 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 6,177 | 0.77 | 4.7K | 141,106 | D | ↗ |
| 2025-06-12 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 12,500 | 0.59 | 7.4K | 2,331,722 | D | ↗ |
| 2025-06-03 | Innes Guy Archibald | Director | P-Purchase | A | Common Stock | 20,000 | 0.54 | 10.8K | 888,689 | D | ↗ |
| 2025-06-01 | Rubin Ethel | Director | A-Award | A | Common Stock | 11,983 | 0.00 | — | 45,524 | D | ↗ |
| 2025-06-01 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 10,190 | 0.00 | — | 147,763 | D | ↗ |
| 2025-06-01 | Retter Andrew | Officer | F-InKind | D | Common Stock | 4,598 | 0.50 | 2.3K | 142,175 | D | ↗ |
| 2025-06-01 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 16,086 | 0.00 | — | 193,714 | D | ↗ |
| 2025-06-01 | Nguyen Kim | Director | A-Award | A | Common Stock | 11,983 | 0.00 | — | 98,392 | D | ↗ |
| 2025-06-01 | Michel Gaetan | Officer | F-InKind | D | Common Stock | 7,835 | 0.50 | 3.9K | 380,441 | D | ↗ |
| 2025-06-01 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 21,526 | 0.50 | 10.8K | 404,507 | D | ↗ |
| 2025-06-01 | Kway Jasmine | Officer | A-Award | A | Common Stock | 8,327 | 0.00 | — | 191,107 | D | ↗ |
| 2025-06-01 | Hughes Terig | Officer | A-Award | A | Common Stock | 17,406 | 0.00 | — | 407,627 | D | ↗ |
| 2025-06-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 1,996 | 0.77 | 1.5K | 159,466 | D | ↗ |
| 2025-06-01 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 11,683 | 0.50 | 5.9K | 314,379 | D | ↗ |
| 2025-06-01 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 18,341 | 0.00 | — | 147,283 | D | ↗ |
| 2025-05-19 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.44 | 8.7K | 2,319,222 | D | ↗ |
| 2025-05-19 | Micallef Jacob Vincent | Officer | P-Purchase | A | Common Stock | 50,000 | 0.43 | 21.5K | 426,033 | D | ↗ |
| 2025-05-01 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 5,453 | 0.49 | 2.7K | 137,573 | D | ↗ |
| 2025-05-01 | Michel Gaetan | Officer | F-InKind | D | Common Stock | 6,844 | 0.49 | 3.3K | 388,276 | D | ↗ |
| 2025-05-01 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 18,319 | 0.49 | 8.9K | 376,033 | D | ↗ |
| 2025-05-01 | Forterre Gael | Officer | F-InKind | D | Common Stock | 3,698 | 0.49 | 1.8K | 159,006 | D | ↗ |
| 2025-05-01 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 10,205 | 0.49 | 5.0K | 302,685 | D | ↗ |
| 2025-03-26 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 181,818 | 0.55 | 100.0K | 2,299,222 | D | ↗ |
| 2025-03-26 | Innes Guy Archibald | Director | P-Purchase | A | Common Stock | 181,818 | 0.55 | 100.0K | 868,689 | D | ↗ |
| 2025-03-01 | Rubin Ethel | Director | A-Award | A | Common Stock | 9,893 | 0.00 | — | 33,541 | D | ↗ |
| 2025-03-01 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 7,908 | 0.00 | — | 143,026 | D | ↗ |
| 2025-03-01 | Retter Andrew | Officer | A-Award | A | Common Stock | 10,142 | 0.00 | — | 137,617 | D | ↗ |
| 2025-03-01 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 12,483 | 0.00 | — | 177,628 | D | ↗ |
| 2025-03-01 | Nguyen Kim | Director | A-Award | A | Common Stock | 9,893 | 0.00 | — | 86,409 | D | ↗ |
| 2025-03-01 | Kway Jasmine | Officer | A-Award | A | Common Stock | 16,708 | 0.00 | — | 182,780 | D | ↗ |
| 2025-03-01 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 19,786 | 0.00 | — | 686,871 | D | ↗ |
| 2025-03-01 | Hughes Terig | Officer | A-Award | A | Common Stock | 13,969 | 0.00 | — | 390,221 | D | ↗ |
| 2025-03-01 | Forterre Gael | Officer | A-Award | A | Common Stock | 5,523 | 0.00 | — | 162,704 | D | ↗ |
| 2025-03-01 | Colman Alan | Director | A-Award | A | Common Stock | 14,840 | 0.00 | — | 245,364 | D | ↗ |
| 2025-03-01 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 19,300 | 0.00 | — | 312,890 | D | ↗ |
| 2025-03-01 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 14,233 | 0.00 | — | 128,942 | D | ↗ |
| 2025-01-29 | Rootsaert Rodney Gerard | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.25 | 162.5K | 50,000 | D | ↗ |
| 2025-01-29 | Reynolds Cameron John | Director / Officer | D-Return | D | Stock Option (Right to Buy) | 50,000 | 3.25 | 162.5K | 0 | D | ↗ |
| 2025-01-29 | Micallef Jacob Vincent | Officer | D-Return | D | Stock Option (Right to Buy) | 50,000 | 3.25 | 162.5K | 0 | D | ↗ |
| 2025-01-29 | Kway Jasmine | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.25 | 162.5K | 50,000 | D | ↗ |
| 2025-01-29 | Innes Guy Archibald | Director | D-Return | D | Stock Option (Right to Buy) | 25,000 | 3.25 | 81.3K | 0 | D | ↗ |
| 2025-01-29 | Colman Alan | Director | D-Return | D | Stock Option (Right to Buy) | 25,000 | 3.25 | 81.3K | 0 | D | ↗ |
| 2025-01-29 | Batchelor Ann-Louise | Officer | D-Return | D | Stock Option (Right to Buy) | 40,000 | 3.25 | 130.0K | 0 | I | ↗ |
| 2025-01-15 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 667,085 | D | ↗ |
| 2024-12-09 | STILL TIMOTHY I | Director | P-Purchase | A | Common Stock | 87,382 | 0.57 | 50.0K | 1,487,382 | D | ↗ |
| 2024-12-09 | Reynolds Cameron John | Director / Officer | P-Purchase | A | Common Stock | 139,811 | 0.57 | 80.0K | 2,117,404 | D | ↗ |
| 2024-12-09 | Micallef Jacob Vincent | Officer | P-Purchase | A | Common Stock | 43,691 | 0.57 | 25.0K | 394,352 | D | ↗ |
| 2024-12-09 | Innes Guy Archibald | Director | P-Purchase | A | Common Stock | 174,764 | 0.57 | 100.0K | 617,085 | D | ↗ |
| 2024-12-01 | Rubin Ethel | Director | A-Award | A | Common Stock | 8,648 | 0.00 | — | 23,648 | D | ↗ |
| 2024-12-01 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 7,302 | 0.00 | — | 135,118 | D | ↗ |
| 2024-12-01 | Retter Andrew | Officer | A-Award | A | Common Stock | 9,365 | 0.00 | — | 127,475 | D | ↗ |
| 2024-12-01 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 11,527 | 0.00 | — | 165,145 | D | ↗ |
| 2024-12-01 | Nguyen Kim | Director | A-Award | A | Common Stock | 8,648 | 0.00 | — | 76,516 | D | ↗ |
| 2024-12-01 | Kway Jasmine | Officer | A-Award | A | Common Stock | 15,169 | 0.00 | — | 166,072 | D | ↗ |
| 2024-12-01 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 17,296 | 0.00 | — | 442,321 | D | ↗ |
| 2024-12-01 | Hughes Terig | Officer | A-Award | A | Common Stock | 12,683 | 0.00 | — | 376,252 | D | ↗ |
| 2024-12-01 | Forterre Gael | Officer | A-Award | A | Common Stock | 4,828 | 0.00 | — | 157,181 | D | ↗ |
| 2024-12-01 | Colman Alan | Director | A-Award | A | Common Stock | 12,972 | 0.00 | — | 230,524 | D | ↗ |
| 2024-12-01 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 16,871 | 0.00 | — | 293,590 | D | ↗ |
| 2024-12-01 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 13,143 | 0.00 | — | 114,709 | D | ↗ |
| 2024-11-06 | STILL TIMOTHY I | Director | A-Award | A | Common Stock | 1,000,000 | 0.00 | — | 1,400,000 | D | ↗ |
| 2024-10-04 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 4,620 | 0.88 | 4.1K | 127,816 | D | ↗ |
| 2024-10-04 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 8,146 | 0.88 | 7.2K | 153,618 | D | ↗ |
| 2024-10-04 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 5,200 | 0.88 | 4.6K | 350,661 | D | ↗ |
| 2024-10-04 | Forterre Gael | Officer | F-InKind | D | Common Stock | 5,433 | 0.88 | 4.8K | 152,353 | D | ↗ |
| 2024-10-04 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 5,834 | 0.88 | 5.2K | 276,719 | D | ↗ |
| 2024-10-04 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 6,110 | 0.88 | 5.4K | 101,566 | D | ↗ |
| 2024-09-30 | Rubin Ethel | Director | — | — | No securities are beneficially owned | 0 | 0.00 | — | 0 | D | ↗ |
| 2024-09-28 | Rootsaert Rodney Gerard | Officer | F-InKind | D | Common Stock | 4,158 | 0.58 | 2.4K | 132,436 | D | ↗ |
| 2024-09-28 | Plummer Nicholas | Officer | F-InKind | D | Common Stock | 1,497 | 0.58 | 865.27 | 161,764 | D | ↗ |
| 2024-09-28 | Micallef Jacob Vincent | Officer | F-InKind | D | Common Stock | 4,950 | 0.58 | 2.9K | 355,861 | D | ↗ |
| 2024-09-28 | Forterre Gael | Officer | F-InKind | D | Common Stock | 4,824 | 0.58 | 2.8K | 157,786 | D | ↗ |
| 2024-09-28 | Butera Salvatore Thomas | Officer | F-InKind | D | Common Stock | 5,230 | 0.58 | 3.0K | 282,553 | D | ↗ |
| 2024-09-28 | Batchelor Ann-Louise | Officer | F-InKind | D | Common Stock | 5,604 | 0.58 | 3.2K | 107,676 | D | ↗ |
| 2024-09-01 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 15,258 | 0.00 | — | 136,594 | — | ↗ |
| 2024-09-01 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 103,243 | 0.00 | — | 1,977,593 | — | ↗ |
| 2024-09-01 | Retter Andrew | Officer | A-Award | A | Common Stock | 9,784 | 0.00 | — | 118,110 | — | ↗ |
| 2024-09-01 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 12,043 | 0.00 | — | 163,261 | — | ↗ |
| 2024-09-01 | Nguyen Kim | Director | A-Award | A | Common Stock | 9,171 | 0.00 | — | 67,868 | — | ↗ |
| 2024-09-01 | Michel Gaetan | Officer | A-Award | A | Common Stock | 15,671 | 0.00 | — | 395,120 | — | ↗ |
| 2024-09-01 | Micallef Jacob Vincent | Officer | A-Award | A | Common Stock | 47,837 | 0.00 | — | 360,811 | — | ↗ |
| 2024-09-01 | Kway Jasmine | Officer | A-Award | A | Common Stock | 15,668 | 0.00 | — | 150,903 | — | ↗ |
| 2024-09-01 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 18,342 | 0.00 | — | 425,025 | — | ↗ |
| 2024-09-01 | Hughes Terig | Officer | A-Award | A | Common Stock | 13,493 | 0.00 | — | 363,569 | — | ↗ |
| 2024-09-01 | Forterre Gael | Officer | A-Award | A | Common Stock | 10,240 | 0.00 | — | 162,610 | — | ↗ |
| 2024-09-01 | Colman Alan | Director | A-Award | A | Common Stock | 13,757 | 0.00 | — | 217,552 | — | ↗ |
| 2024-09-01 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 35,783 | 0.00 | — | 287,783 | — | ↗ |
| 2024-09-01 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 13,731 | 0.00 | — | 113,280 | — | ↗ |
| 2024-09-01 | Barnes Phillip | Director | A-Award | A | Common Stock | 9,171 | 0.00 | — | 55,368 | — | ↗ |
| 2024-08-20 | Innes Guy Archibald | Director | P-Purchase | A | Common Stock | 150,000 | 0.67 | 100.5K | 406,683 | — | ↗ |
| 2024-08-15 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 11,000 | 0.00 | — | 121,336 | — | ↗ |
| 2024-08-15 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 29,500 | 0.00 | — | 1,874,350 | — | ↗ |
| 2024-08-15 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 17,250 | 0.00 | — | 151,218 | — | ↗ |
| 2024-08-15 | Nguyen Kim | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 58,697 | — | ↗ |
| 2024-08-15 | Michel Gaetan | Officer | A-Award | A | Common Stock | 25,250 | 0.00 | — | 379,449 | — | ↗ |
| 2024-08-15 | Micallef Jacob Vincent | Officer | A-Award | A | Common Stock | 13,750 | 0.00 | — | 312,974 | — | ↗ |
| 2024-08-15 | Kway Jasmine | Officer | A-Award | A | Common Stock | 16,750 | 0.00 | — | 135,235 | — | ↗ |
| 2024-08-15 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 256,683 | — | ↗ |
| 2024-08-15 | Hughes Terig | Officer | A-Award | A | Common Stock | 19,500 | 0.00 | — | 350,076 | — | ↗ |
| 2024-08-15 | Henshall Mickie | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 32,206 | — | ↗ |
| 2024-08-15 | Forterre Gael | Officer | A-Award | A | Common Stock | 15,250 | 0.00 | — | 152,370 | — | ↗ |
| 2024-08-15 | Colman Alan | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 203,795 | — | ↗ |
| 2024-08-15 | Butera Salvatore Thomas | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 252,000 | — | ↗ |
| 2024-08-15 | Batchelor Ann-Louise | Officer | A-Award | A | Common Stock | 13,250 | 0.00 | — | 99,549 | — | ↗ |
| 2024-08-15 | Barnes Phillip | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 46,197 | — | ↗ |
| 2024-07-04 | Innes Guy Archibald | Director | G-Gift | D | Common Stock | 400,000 | 0.00 | — | 251,683 | — | ↗ |
| 2024-06-01 | Rootsaert Rodney Gerard | Officer | A-Award | A | Common Stock | 12,984 | 0.00 | — | 110,336 | — | ↗ |
| 2024-06-01 | Reynolds Cameron John | Director / Officer | A-Award | A | Common Stock | 90,182 | 0.00 | — | 1,844,850 | — | ↗ |
| 2024-06-01 | Retter Andrew | Officer | A-Award | A | Common Stock | 8,326 | 0.00 | — | 108,326 | — | ↗ |
| 2024-06-01 | Plummer Nicholas | Officer | A-Award | A | Common Stock | 10,249 | 0.00 | — | 133,968 | — | ↗ |
| 2024-06-01 | Nguyen Kim | Director | A-Award | A | Common Stock | 8,011 | 0.00 | — | 53,697 | — | ↗ |
| 2024-06-01 | Michel Gaetan | Officer | A-Award | A | Common Stock | 13,689 | 0.00 | — | 354,199 | — | ↗ |
| 2024-06-01 | Micallef Jacob Vincent | Officer | A-Award | A | Common Stock | 40,709 | 0.00 | — | 299,224 | — | ↗ |
| 2024-06-01 | Kway Jasmine | Officer | A-Award | A | Common Stock | 13,570 | 0.00 | — | 118,485 | — | ↗ |
| 2024-06-01 | Innes Guy Archibald | Director | A-Award | A | Common Stock | 16,022 | 0.00 | — | 651,683 | — | ↗ |
| 2024-06-01 | Hughes Terig | Officer | A-Award | A | Common Stock | 11,686 | 0.00 | — | 330,576 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.1K
Shares Outstanding
5.35M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Cameron Reynolds President and Chief Executive Officer | 351.9K | 33.6K | 198.8K | — | — | 30.5K | 614.8K | 32.33% | ↗ |
| 2 | 2024 | Dr. Gaetan Michel Chief Operating Officer | 293.6K | 30.4K | 86.7K | — | — | 110.3K | 521.0K | 16.64% | ↗ |
| 3 | 2024 | Dr. Salvatore Thomas Butera Chief Executive Officer, Volition Vet | 289.0K | 24.0K | 99.8K | — | — | 15.6K | 428.4K | 23.29% | ↗ |
| 4 | 2023 | Cameron Reynolds President and Chief Executive Officer | 391.0K | 39.5K | 174.2K | 26.3K | — | 141.9K | 772.9K | 25.94% | ↗ |
| 5 | 2023 | Dr. Gaetan Michel Chief Operating Officer | 394.7K | 58.9K | 125.4K | 24.3K | — | 64.5K | 667.8K | 22.41% | ↗ |
| 6 | 2023 | Dr. Salvatore Thomas Butera Chief Executive Officer, Volition Vet | 332.8K | 128.6K | 127.5K | 15.1K | — | 15.9K | 619.8K | 23.00% | ↗ |
| 7 | 2022 | Cameron Reynolds President and Chief Executive Officer | — | — | 124.8K | 97.2K | — | 28.8K | 760.6K | 29.18% | ↗ |
| 8 | 2022 | Dr. Salvatore Thomas Butera Chief Executive Officer, Volition Vet | 297.7K | 100.0K | 206.3K | 55.7K | — | 16.5K | 676.1K | 38.75% | ↗ |
| 9 | 2022 | Dr. Gaetan Michel Chief Operating Officer | 331.2K | 54.7K | 100.2K | 80.4K | — | 27.1K | 625.6K | 28.86% | ↗ |
| 10 | 2022 | Terig Hughes Chief Financial Officer | 270.3K | 43.5K | 75.3K | 99.2K | — | 24.9K | 513.2K | 34.00% | ↗ |
| 11 | 2021 | Cameron Reynolds President and Chief Executive Officer | — | — | 50.9K | 97.5K | — | 365.3K | 981.9K | 15.11% | ↗ |
| 12 | 2021 | Terig Hughes Chief Financial Officer | 245.3K | 20.2K | 31.5K | 454.6K | — | 830.00 | 752.4K | 64.61% | ↗ |
| 13 | 2021 | Dr. Jacob Micallef Chief Scientific Officer | 209.1K | 16.9K | 24.7K | 61.6K | — | 345.6K | 657.9K | 13.12% | ↗ |
| 14 | 2021 | Dr. Gaetan Michel Chief Operating Officer | 212.2K | — | 22.1K | 23.4K | — | 10.0K | 358.9K | 12.66% | ↗ |
| 15 | 2020 | Cameron Reynolds President and Chief Executive Officer | 363.7K | — | — | 108.7K | — | 18.2K | 562.9K | 19.31% | ↗ |
| 16 | 2020 | Dr. Jason Terrell Chief Medical Officer | 323.5K | 25.8K | — | 90.7K | — | 7.1K | 447.0K | 20.28% | ↗ |
| 17 | 2020 | Dr. Jacob Micallef Chief Scientific Officer | 195.1K | 17.0K | — | 89.5K | — | 4.2K | 305.8K | 29.27% | ↗ |
| 18 | 2019 | Cameron Reynolds President and Chief Executive Officer | 390.6K | — | — | 107.5K | — | 19.6K | 517.7K | 20.77% | ↗ |
| 19 | 2019 | Dr. Jason Terrell Chief Medical Officer | 321.6K | — | — | 107.5K | — | 7.0K | 436.1K | 24.65% | ↗ |
| 20 | 2019 | David Vanston Chief Financial Officer and Treasurer | 199.3K | — | — | 107.5K | — | 10.0K | 316.8K | 33.94% | ↗ |
| 21 | 2019 | Dr. Jacob Micallef Chief Scientific Officer | 191.3K | — | — | 107.5K | — | — | 298.8K | 35.98% | ↗ |
| 22 | 2018 | Cameron Reynolds President, CEO and Director | 398.2K | — | — | 241.4K | — | 19.9K | 659.5K | 36.60% | ↗ |
| 23 | 2018 | Cameron Reynolds President and Chief Executive Officer | 398.2K | — | — | 241.4K | — | 19.9K | 659.5K | 36.60% | ↗ |
| 24 | 2018 | David Vanston Chief Financial Officer and Treasurer | 203.2K | — | — | 209.8K | — | 10.2K | 423.2K | 49.59% | ↗ |
| 25 | 2018 | Dr. Jacob Micallef Chief Scientific Officer | 195.0K | — | — | 221.1K | — | — | 416.2K | 53.14% | ↗ |
| 26 | 2018 | Dr. Jason Terrell Chief Medical Officer | 212.3K | — | — | 158.3K | — | 21.6K | 392.2K | 40.35% | ↗ |
| 27 | 2017 | Cameron Reynolds President, CEO and Director | 294.0K | — | — | 303.7K | — | 92.4K | 690.0K | 44.01% | ↗ |
| 28 | 2017 | Dr. Martin Faulkes Executive Chairman and Director | 178.4K | — | — | 258.3K | — | — | 436.8K | 59.15% | ↗ |
| 29 | 2017 | Dr. Jacob Micallef Chief Scientific Officer | 140.9K | — | — | 240.9K | — | 37.6K | 419.4K | 57.44% | ↗ |
| 30 | 2017 | David Vanston Chief Financial Officer and Treasurer | 141.1K | — | — | 187.4K | — | 5.0K | 333.4K | 56.20% | ↗ |
| 31 | 2016 | Cameron Reynolds President, CEO and Director | 25.0K | — | — | 257.7K | — | 285.2K | 567.9K | 45.38% | ↗ |
| 32 | 2016 | Dr. Jacob Micallef Chief Scientific Officer | — | — | — | 260.2K | — | 151.6K | 411.7K | 63.19% | ↗ |
| 33 | 2016 | Dr. Martin Faulkes Executive Chairman and Director | 151.8K | — | — | 137.9K | — | — | 289.8K | 47.60% | ↗ |
| 34 | 2016 | Rodney Rootsaert Corporate Secretary | 126.2K | — | — | 136.5K | — | — | 262.7K | 51.95% | ↗ |
| 35 | 2016 | David Kratochvil Former CFO and Treasurer | 223.3K | — | — | 24.3K | — | 9.7K | 257.3K | 9.43% | ↗ |
| 36 | 2016 | Dr. Jason Terrell Chief Medical Officer | 120.0K | — | — | 48.8K | 62.3K | — | 231.2K | 21.12% | ↗ |
| 37 | 2015 | Cameron Reynolds President, CEO and Director | 121.7K | — | — | 199.3K | — | 145.3K | 466.3K | 42.74% | ↗ |
| 38 | 2015 | Dr. Jacob Micallef Chief Scientific Officer | — | 46.8K | — | 224.9K | — | 147.2K | 418.9K | 53.69% | ↗ |
| 39 | 2015 | David Kratochvil CFO and Treasurer | 82.5K | — | — | 165.6K | — | 32.9K | 280.9K | 58.94% | ↗ |
| 40 | 2015 | David Kratochvil Former CFO and Treasurer | 82.5K | — | — | 165.6K | — | 32.9K | 280.9K | 58.94% | ↗ |
| 41 | 2015 | Rodney Rootsaert Corporate Secretary | 118.4K | — | — | 123.2K | — | 4.1K | 245.7K | 50.14% | ↗ |
| 42 | 2015 | Rodney Rootsaert Secretary | 118.4K | — | — | 123.2K | — | 4.1K | 245.7K | 50.14% | ↗ |
| 43 | 2015 | Mike O’Connell Former CFO and Treasurer | — | — | — | 3.3K | — | 167.5K | 170.8K | 1.93% | ↗ |
| 44 | 2015 | Dr. Jason Terrell Chief Medical Officer | — | — | — | 21.3K | — | — | 21.3K | 100.00% | ↗ |
| 45 | 2014 | Dr. Jacob Micallef Chief Scientific Officer | — | — | — | 126.3K | — | 150.8K | 277.1K | 45.57% | ↗ |
| 46 | 2014 | Dr. Mark Eccleston Chief Scientific Officer of HyperGenomics Pte Limited | — | — | — | 126.3K | — | 150.8K | 277.1K | 45.57% | ↗ |
| 47 | 2014 | Malcolm Lewin Former CFO and Treasurer of the Company | — | — | — | 263.0K | — | — | 263.0K | 100.00% | ↗ |
| 48 | 2014 | Dr. Jason Terrell Chief Medical Officer | — | — | — | 240.6K | 22.4K | — | 263.0K | 91.49% | ↗ |
| 49 | 2014 | Mike O’Connell CFO and Treasurer of the Company | — | — | — | 126.3K | — | 126.5K | 252.8K | 49.96% | ↗ |
| 50 | 2014 | Dr. Jacob Micallef Chief Scientific Officer and Director of Belgian Volition | — | — | — | 99.4K | — | 141.9K | 241.3K | 41.20% | ↗ |
| 51 | 2014 | Cameron Reynolds President, CEO and Director | — | — | — | 99.4K | — | 129.1K | 228.6K | 43.50% | ↗ |
| 52 | 2014 | Jason Terrell Chief Medical Officer and Head of U.S. Operations for the Company | — | — | — | 58.7K | — | 84.3K | 143.0K | 41.03% | ↗ |
| 53 | 2014 | Rodney Rootsaert Secretary | — | — | — | 58.7K | — | 84.3K | 143.0K | 41.03% | ↗ |
| 54 | 2014 | Rodney Rootsaert Secretary of the Company | — | — | — | 32.6K | — | 107.6K | 140.2K | 23.28% | ↗ |
| 55 | 2014 | Mike O’Connell Former CFO and Treasurer | — | — | — | 32.6K | — | 107.6K | 140.2K | 23.28% | ↗ |
| 56 | 2013 | Jason Terrell Chief Medical Officer and Head of U.S. Operations for the Company | — | — | — | 198.6K | — | — | 198.6K | 100.00% | ↗ |
| 57 | 2013 | Dr Jacob Micallef Chief Scientific Officer and Director of Belgian Volition | — | — | — | 31.3K | — | 132.0K | 163.3K | 19.17% | ↗ |
| 58 | 2013 | Cameron Reynolds President, CEO and Director of the Company | — | — | — | 31.3K | — | 132.0K | 163.3K | 19.17% | ↗ |
| 59 | 2013 | Dr Mark Eccleston Chief Scientific Officer of Hypergenomics Pte Limited | — | — | — | 31.3K | — | 102.5K | 133.8K | 23.41% | ↗ |
| 60 | 2013 | Dr. Jacob Micallef Chief Scientific Officer and Director of Belgian Volition | — | — | — | 31.3K | — | 102.5K | 133.8K | 23.41% | ↗ |
| 61 | 2013 | Malcolm Lewin CFO and Treasurer of the Company, CFO of Singapore Volition and Director of Belgian Volition | — | — | — | 31.3K | — | 100.5K | 131.8K | 23.76% | ↗ |
| 62 | 2013 | Dr. Mark Eccleston Chief Scientific Officer of HyperGenomics Pte Limited | — | — | — | 31.3K | — | 100.5K | 131.8K | 23.76% | ↗ |
| 63 | 2013 | Rodney Rootsaert Secretary of the Company | — | — | — | 15.7K | — | 85.6K | 101.3K | 15.46% | ↗ |
| 64 | 2013 | Rodney Rootsaert Secretary of the Company, Administration and Legal Officer of Singapore Volition and Secretary and Director of Belgian Volition | — | — | — | 15.7K | — | 78.0K | 93.7K | 16.72% | ↗ |
| 65 | 2013 | Malcolm Lewin Former CFO and Treasurer of the Company | — | — | — | 15.7K | — | 78.0K | 93.7K | 16.72% | ↗ |
| 66 | 2013 | Mike O’Connell CFO and Treasurer of the Company | — | — | — | — | — | — | — | — | ↗ |
| 67 | 2012 | Dr Mark Eccleston Chief Scientific Officer of Hypergenomics Pte Limited | — | — | — | 239.5K | — | 105.0K | 344.6K | 69.52% | ↗ |
| 68 | 2012 | Dr Jacob Micallef Chief Scientific Officer and Director of Belgian Volition | — | — | — | 239.5K | — | 104.3K | 343.8K | 69.67% | ↗ |
| 69 | 2012 | Cameron Reynolds President, CEO and Director of the Company; CEO and Director of Singapore Volition; Managing Director of Belgian Volition; and CEO and Director of Hypergenomics Pte Limited | — | — | — | 86.5K | — | 132.0K | 218.5K | 39.60% | ↗ |
| 70 | 2012 | Rodney Rootsaert Secretary of the Company, Administration and Legal Officer of Singapore Volition and Secretary and Director of Belgian Volition | — | — | — | 43.3K | — | 85.8K | 129.1K | 33.52% | ↗ |
| 71 | 2012 | Malcolm Lewin CFO and Treasurer of the Company, CFO of Singapore Volition and Director of Belgian Volition | — | — | — | 43.3K | — | 69.0K | 112.3K | 38.54% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jacob Vincent Micallef | Chief Scientific Officer | 571.6K | — |
| Cameron Reynolds | Founder, Chief Executive Officer, President & Director | 505.7K | male |
| Gaetan Michel | Chief Operating Officer | 439.6K | — |
| Terig Hughes | Chief Financial Officer & Treasurer | 338.7K | male |
| Rodney Gerard Rootsaert | Corporate Secretary | 126.2K | male |
| Jasmine Kway | Chief Executive Officer of Singapore Volition | — | — |
| Louise Batchelor Day | Group Chief Marketing & Communications Officer | — | female |
| Nicholas Plummer | Group General Counsel | — | male |
| Sharon Ballesteros | U.S. Head of Quality & Development Process | — | female |
| Gael Forterre | Chief Commercial Officer | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VNRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
